Re: Hughes et al.: Cost-effectiveness analysis of adalimumab for the treatment of uveitis associated with juvenile idiopathic arthritis (Ophthalmology. 2019;126:415-424).

Brown, Gary C; Brown, Melissa M

Re: Hughes et al.: Cost-effectiveness analysis of adalimumab for the treatment of uveitis associated with juvenile idiopathic arthritis (Ophthalmology. 2019;126:415-424).

Brown, Gary C; Brown, Melissa M.

Afiliação

Brown GC; Center for Value-Based Medicine, Hilton Head, South Carolina; Wills Eye Hospital, Philadelphia, Pennsylvania; The Eye Research Institute, Philadelphia, Pennsylvania; Thomas Jefferson Medical University, Philadelphia, Pennsylvania; Department of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia. Electronic address: gary0514@gmail.com.
Brown MM; Center for Value-Based Medicine, Hilton Head, South Carolina; Wills Eye Hospital, Philadelphia, Pennsylvania; The Eye Research Institute, Philadelphia, Pennsylvania; Thomas Jefferson Medical University, Philadelphia, Pennsylvania; Department of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia.

Ophthalmology ; 126(10): e76, 2019 10.

Article em En | MEDLINE | ID: mdl-31543114

Assuntos

Antirreumáticos; Artrite Juvenil; Uveíte; Adalimumab; Análise Custo-Benefício; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Juvenil / Uveíte / Antirreumáticos Tipo de estudo: Health_economic_evaluation / Risk_factors_studies Limite: Humans Idioma: En Revista: Ophthalmology Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google